Point72 Asset Management, L.P. 13D and 13G filings for Bright Minds Biosciences Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 4:06 pm Sale | 2024-12-31 | 13G | Bright Minds Biosciences Inc. DRUG | Point72 Asset Management, L.P. | 135,189 3.000% | -299,811 (-68.92%) | Filing |
| 2024-10-23 6:01 pm Purchase | 2024-10-16 | 13G | Bright Minds Biosciences Inc. DRUG | Point72 Asset Management, L.P. | 435,000 9.700% | 435,000 (New Position) | Filing |